The assessment and management of tuberculous meningitis (TBM) is often complex, yet no standardised approach exists, and evidence for the clinical care of patients, including those with critical illness, is limited. The roles of proformas and checklists are increasing in medicine; proformas provide a framework for a thorough approach to patient care, whereas checklists offer a priority-based approach that may be applied to deteriorating patients in time-critical situations. We aimed to develop a comprehensive assessment proforma and an accompanying 'priorities' checklist for patients with TBM, with the overriding goal being to improve patient outcomes. The proforma outlines what should be asked, checked, or tested at initial evaluation and daily inpatient review to assist supportive clinical care for patients, with an adapted list for patients in critical care. It is accompanied by a supporting document describing why these points are relevant to TBM. Our priorities checklist offers a useful and easy reminder of important issues to review during a time-critical period of acute patient deterioration. The benefit of these documents to patient outcomes would require investigation; however, we hope they will promote standardisation of patient assessment and care, particularly of critically unwell individuals, in whom morbidity and mortality remains unacceptably high.
Introduction
Tuberculous meningitis (TBM) is the most severe form of tuberculosis (TB) and causes critical illness from direct neurological injury or complications from the infection, treatment, or prolonged hospitalisation.
Due to serious complications, the management of TBM is complex, and includes supportive medical and neurosurgical measures. Currently there are no guidelines or standardised approach for the assessment and management of TBM. This is due to limited literature to develop an evidence-based approach, and because each TBM patient is unique. However, common themes exist, and a comprehensive proforma to guide patient assessment could be the first step towards standardised management.
Checklists can be powerful tools to focus attention 1 and their use in the medical field is growing [2] [3] [4] . We aimed to develop a comprehensive proforma for the assessment and management of TBM as well as a priorities checklist for the decompensating patient. The document cannot account for every scenario, but is designed to identify priorities; i.e. potentially reversible factors that contribute to morbidity and mortality. Local modifications to increase uptake and tailor use to suit local needs are encouraged.
Accompanying our proforma and checklist is the rationale for why these assessments may be important. Importantly, this article is not a guideline and does not make recommendations for care. It is not intended to replace a comprehensive ward round, nor to increase the clinical workload. Instead, it should provide a framework to highlight vital components during different stages of TBM care, with many complications overlapping throughout illness. We acknowledge that investigations and procedures will not be available at all centres.
Comprehensive proforma
The comprehensive proforma is split into initial evaluation (Table 1) , daily inpatient review (Table 2) , and critical care in the intensive care unit (ICU) ( Table 3) . However, as elements can occur at any time, the rationale is grouped by themes within sections titled "General supportive and critical care" and "Neurocritical care".
General supportive and critical care
History of present illness Obtaining a thorough history of the patient's signs and symptoms is paramount (Table 1 and Box 1).
Box 1. Key predictors of poor outcome in tuberculous meningitis
Increased Medical Research Council TBM disease severity [5] [6] [7] [8] Reduced consciousness 6, 9 Hydrocephalus and raised ICP 8, 10, 11 Cerebral infarction 6, 12 Seizures 12, 13 HIV co-infection 9, 14 Multidrug resistant, or isoniazid mono-resistant, disease 15 Lower body weight 5 Younger and older age 5, 16 General clinical examination and monitoring General assessment and non-invasive monitoring of vital signs may be the only tools available to guide patient management in many centres. These provide valuable information in all care settings, and are mentioned in Table 1-Table 4 .
Respiratory monitoring.
A change in neurological status may cause hypoxia due to airway compromise, and pulse oximetry may raise the alarm. Chest X-rays can help diagnose pulmonary TB, and other complications such as pneumothorax (especially in Pneumocystis jiroveci pneumonia co-infected TBM patients with HIV).
Heart rate monitoring. Bradycardia may be caused by raised intracranial pressure (ICP) or brainstem ischaemia, and the development of tachycardia or bradycardia could indicate new infection or hypovolemia.
Blood pressure monitoring. Blood pressure monitoring may detect septic shock or cerebral salt wasting (CSW)-associated hypotension. It may also help calculate cerebral perfusion pressure (CPP).
Temperature monitoring. Fever is associated with worse outcomes in neurocritical care and an increased one-year mortality in HIV-uninfected individuals with TBM 9 . Pyrexia may indicate superimposed bacterial infection. '✓' can be selected when a proforma question has been answered, or a proforma point has been reviewed or tested. 
Category Specific question or assessment ✓

General clinical examination
Weight and nutritional status (i.e., use of oral feeds, intravenous fluids, etc.)
Monitor for vomiting/inability to take drugs orally
Monitor for gastrointestinal bleeding
Vital signs (i.e., oxygen saturation, heart rate, blood pressure, temperature)
Hydration status (i.e., fluid input and output, clinical signs of dehydration, CVP, IVC ultrasound)
Medication evaluation
Have any doses of anti-TB chemotherapy been missed?
Monitor for side effects from anti-TB chemotherapy Check drug susceptibility testing results. Are changes to anti-TB chemotherapy required?
Monitor recent liver function and renal function panels for medication toxicity
Repeat liver function and renal function panels if toxicity concerns remain
Check corticosteroid dose Schedule corticosteroid taper (i.e., when to reduce the dose)
Neurological examination
Level of consciousness (i.e., GCS, modified for infants)
Assess for papilloedema by fundoscopy
Focal neurological deficits (i.e., cranial nerve palsies, hemiplegia, paraplegia, tetraplegia, urinary retention)
Has there been a change in examination since last review? If so, what is the suspected cause?
Does the patient need repeat neuroimaging?
Laboratory tests (blood)
Repeat complete full blood count and inflammatory markers (i.e., if concern for other infection) 
Repeat complete full blood count and inflammatory markers (i.e., if concern for other infection)
Repeat '✓' can be selected when a proforma question has been answered, or a proforma point has been reviewed or tested. Medication evaluation and management Important characteristics to monitor for anti-TB chemotherapy are described below and in Table 2 .
Anti-tuberculosis chemotherapy. The optimum delivery of essential anti-TB chemotherapy is a priority, but optimal doses and administration routes are unknown 17 . Prompt treatment and avoidance of therapy interruptions are essential to reduce mortality, and in unconscious patients, crushed medication administered via nasogastric tube, or intravenous therapy, may be considered 17,18 .
Anti-TB chemotherapy can change during the long duration of treatment. Regimen modifications may be necessitated by drug resistance, changes in weight, interactions with cytochrome P450-inhibiting anti-retroviral therapy (ART), and drug side effects, many of which cause and exacerbate critical illness 17 . Rifampicin, isoniazid, pyrazinamide and fluoroquinolones can cause liver injury; therefore, regular monitoring of alanine transaminase (ALT), aspartate aminotransferase (AST), and bilirubin is important. Optimal management of drug-induced liver injury in TBM is unknown and is currently being studied 19, 20 .
Nutrition and the gastrointestinal tract TB causes a chronic catabolic illness and patients commonly present with weight loss or failure to thrive in children. Additionally, TBM patients are at risk of the negative consequences of the catabolic stress of critical illness 21 . Controlling glycaemia may be complicated by corticosteroids, which increase serum glucose. Nutrition in TBM often requires nasogastric tube placement when consciousness is reduced. Maintaining adequate nutrition is important to provide substrate for healing. Early feeding and avoidance of hypoglycaemia may improve outcomes after acute brain injury 22 , but has not been studied in TBM.
Multidrug regimens, corticosteroids and anti-platelet drugs can lead to gastrointestinal intolerance and bleeding 23 . Gastrointestinal bleeding may cause hypovolaemia and exacerbate reduced cerebral perfusion. Nausea and vomiting, common side effects of anti-TB chemotherapy, may further contribute to hypovolaemia. Aspiration of vomited gastric contents is a risk when consciousness is impaired. See Table 1 and Table 2 .
Kidney function, fluid balance, and electrolytes Kidney function. Acute dehydration may place patients at risk for hypovolemia and prerenal acute kidney injury. Chronic use of anti-TB chemotherapy may be nephrotoxic 24, 25 . Obtaining baseline kidney function tests, including creatinine and urea, may identify those at risk of acute or chronic kidney injury. Changes in urine output or fluid balance may precede laboratory abnormalities. See Table 1 and Table 2 .
Hyponatraemia and fluid balance. Fluid balance is an important distinguishing parameter between the causes of hyponatremia (sodium <135mmol/L). Central venous pressure (CVP) reflects the intravascular volume and helps determine hydration status. CVP can be measured continuously or intermittently from a central venous catheter most often placed in the internal jugular vein or femoral vein if they are available. CSW is often characterised by high volume urine output, hypovolemia with low CVP, clinical signs of dehydration (dry mucous membranes, delayed capillary refill time, tachycardia, and hypotension) and haemoconcentrated laboratory parameters (elevated haematocrit, haemoglobin or urea) 26 . Conversely, the syndrome of inappropriate anti-diuretic hormone (SIADH) lacks a high volume urine output, and patients are usually euvolaemic with a normal CVP, and no clinical signs of dehydration 26 . Fluid balance charts may help identify these fluid shifts. Despite these distinguishing features, CSW and SIADH can be difficult to diagnose and other laboratory tests, such as serum and urinary osmolality and urinary sodium, may help further identify the aetiology, which is critical due to their divergent management approaches.
Hypokalaemia. Hypokalaemia may be a result of drugs or of poor nutrition, whereas hyperkalaemia may be due to hypoadrenalism either directly from TB or from withdrawal of corticosteroids. Monitoring low serum potassium and replacement requires an environment capable of close monitoring. The use of hypertonic saline, fludrocortisone and acetazolamide, individually or in combination, may rapidly shift electrolytes.
Risks of prolonged critical care admission
Pressure ulcers are common in immobile individuals requiring prolonged care. Nosocomial infections occur due to changes in patients' immune system and placement of foreign objects, such as a central venous line, arterial line, urinary catheter or endotracheal tube. Urinary tract infections may occur secondary to urinary catheters. Further, impaired consciousness may require prolonged intubation and mechanical ventilation 27 , which may be associated with a higher risk for gastrointestinal haemorrhage, septicaemia and pressures ulcers 28 . Prolonged recovery and slow ventilator wean may involve tracheostomy placement.
Neurocritical care
In addition to general and critical care management, specific neurocritical care may assist in TBM management.
Neurological examination
Level of consciousness. The Glasgow coma scale (GCS) assesses level of consciousness. It can be confounded by intubation, sedatives, and pre-existing neurological conditions 17,29 . For paediatrics, modified GCS versions have been developed, but are used variably 29 . Decreased GCS (<15) could be due to irreversible neurological injury and also reversible factors including electrolyte disturbances, raised ICP, seizures, and medication. Consequently, the GCS one week post-admission may be a stronger prognostic marker 30 . A deteriorating GCS may signal worsening hydrocephalus, poorly controlled ICP, and progressive ischaemia.
Focal neurological deficits. Palsies commonly involve cranial nerves II, III and VI and can denote nerve arachnoiditis, ischaemia, a mass lesion, or hydrocephalus 31 . Motor weakness and abnormalities may be due to ischaemia, infarction or brain shift.
Cranial examination. An enlarging head may signify subacute or chronic development of hydrocephalus in young children if their sutures are not fused.
General monitoring in neurocritical care
Blood pressure and cerebral perfusion. Maintaining normotension is important for adequate CPP, defined as mean arterial pressure (MAP) minus ICP, which reflects the pressure gradient that drives cerebral blood flow (CBF) 32 . Current treatment guidelines in traumatic brain injury (TBI) recommend maintaining age-appropriate CPP and MAP [32] [33] [34] [35] . Hydration status and overall fluid balance, often compromised by CSW or poor oral intake, can affect MAP and subsequently CPP. TBM-specific goals for CPP and MAP are not established.
Ventilation and oxygenation.
Oxygen administration may increase cerebral oxygenation and possibly reverse brain hypoxia 36 . Oxygen and carbon dioxide (CO 2 ) levels also affect CBF and ICP. Decreased arterial oxygen and increased CO 2 both dilate cerebral vessels, which may increase cerebral blood volume and ICP 37 . Conversely, aggressive hyperventilation may constrict cerebral vessels and cause ischaemia from decreased CBF 37 . Therefore, tight control of end tidal carbon dioxide (ETCO 2 ) is crucial to control raised ICP but avoid ischaemia and is an important parameter in TBI management guidelines, although the target level for TBM in unknown 33, 38 . Both oxygenation and ventilation can be monitored noninvasively with pulse oximetry and ETCO 2 or invasively with arterial blood gases.
Temperature. Hyperthermia may increase cerebral metabolic rate and CBF, which can further increase ICP in a swollen brain 39 . Induced hypothermia is experimentally neuroprotective but is associated with poorer outcomes in TBI 33, 34, 38 . The target temperature in TBM is not established.
Head-of-bed elevation.
Elevating the head end of a bed lowers ICP through improved venous drainage and extracranial shift of cerebrospinal fluid (CSF). However, the MAP may also fall. In non-TBM pathology, studies suggest a beneficial or non-detrimental role of head-of-bed elevation to 30°4 0-42 .
Neuroimaging
Infarcts may not be visible on admission computed tomography (CT) scans 43,44 , but diffusion-weighted magnetic resonance imaging (MRI) is sensitive to acute/evolving infarcts 45, 46 . Follow-up imaging is important to detect new infarcts 43, 44, 47 and, although there are little data on the temporal profile of infarct development, patients appear to be at greatest risk during the acute phase (first month).
Hydrocephalus is the commonest cause of increased ICP in TBM 44, 48 . The communicating nature of hydrocephalus has implications for the safety of lumbar punctures and the method of treatment. However, communication cannot be determined from standard imaging 49 and lumbar exudate can confound determination of the level of CSF obstruction. ICP cannot be estimated from ventricular size alone on imaging 47 . Hydrocephalus may persist or develop de novo over the first six months after treatment initiation; therefore, repeat neuroimaging may be warranted 10,50 .
Tuberculomas and TB abscesses occasionally complicate the management of TBM if they cause local mass effect 51 and precipitate CSF obstruction, focal deficits or seizures 44, 47, 52, 53 . During treatment, paradoxical enlargement of established tuberculomas or development of new tuberculomas may necessitate follow-up imaging 44, 52, [54] [55] [56] .
Repeat neuroimaging can be used to monitor disease progression, evaluate deteriorating patients, and confirm the placement of a ventriculoperitoneal (VP) shunt or an external ventricular drain (EVD). The ideal timing of follow up imaging is unclear in stable patients.
Raised intracranial pressure
Raised ICP is a key factor precipitating adverse outcomes. Firstly, it reduces CPP and exacerbates existing cerebral ischaemia due to vasculitis. Secondly, generalised or compartmentalised increased ICP causes brain shift and consequent neural injury. ICP monitoring is useful; non-invasive monitoring techniques may be used when gold-standard invasive monitoring is unavailable. New monitoring techniques have potential for improving patient care, yet these are not widely available. Important points for the monitoring and optimisation of ICP are shown in Table 3 and Table 4 .
Non-invasive intracranial pressure measurement and monitoring Fundoscopy
Optic disc swelling can indicate raised ICP. However, fundoscopy is challenging to perform and highly operator dependent, and the development of papilloedema can be delayed.
Optic nerve sheath diameter ultrasound
Changes in optic nerve sheath diameter (ONSD) due to raised ICP occur rapidly and can be measured using ultrasound 57 . ONS ultrasound is quick, easy, and reproducible, and correlates with ICP 58,59 , although evidence for its use in TBM is limited 60-62 .
Compromised cerebral perfusion
Various neuromonitors have been used in non-TBM pathologies, to detect ischaemic brain injury 63-65 . These measure various facets of brain perfusion and each have strengths and limitations.
Transcranial Doppler ultrasound
Transcranial Doppler (TCD) can be used to measure flow velocity in basal vessels and detect vasculopathy; however, it may not detect mild-moderate ICP changes, is limited to flow in the major cerebral vessels, and is technically challenging 17,66 .
Non-invasive cerebral oxygenation monitoring: near-infrared spectroscopy.
Near-infrared spectroscopy (NIRS) is a non-invasive monitor that uses optical technology to continuously assess brain oxygenation 67, 68 . NIRS is limited by superficial penetration of cortex, distortion by the skull, CSF and oedema 67,69,70 and poor long term monitoring.
Invasive cerebral oxygenation monitoring: partial pressure of brain tissue oxygen tension. The partial pressure of brain tissue oxygen tension (PbtO2) monitor is a thin parenchymal catheter that offers continuous monitoring of brain oxygenation 65, 71 . Normal values have not been established; however, the risk of poor outcome increases with PbtO2 <20mmHg 72 , especially <10mmHg 63, 71, 73, 74 .
Invasive intracranial pressure measurement and monitoring. CSF opening pressure may be measured from the ventricles with an EVD or via lumbar puncture (when safe) 75 . CSF drainage allows simultaneous ICP monitoring and treatment.
Continuous monitoring is possible with a parenchymal probe.
Post-operative neurosurgery management. This includes wound review, suture removal, and clinical monitoring for signs of treatment failure. Repeat imaging can check treatment success. EVDs must be carefully managed to avoid lifethreatening complications (infection and overdrainage-related intracranial haemorrhage). VP shunts are permanent and therefore complication rates must be viewed over the full lifetime of the patient.
Management of acutely decompensating patients
Causes for acute neurological decompensation include raised ICP, metabolic disturbances (i.e., hyponatremia, hypoglycaemia), stroke (ischaemic or haemorrhagic) and seizures. Table 4 outlines a priorities-based checklist approach to the acutely decompensating patient. The rationale for this checklist is described below, unless already discussed.
Seizures
Clinical and subclinical seizures can increase ICP due to the increased cerebral metabolic demand and resultant increased CBF. Hydrocephalus, infarcts, tuberculomas, and electrolyte imbalance can all precipitate seizures. Anti-convulsants that induce cytochrome P450 enzymes, or are susceptible to enzyme induction by rifampicin, may complicate management.
Hyperosmolar treatment
Intravenous administration of a hyperosmolar solution creates an osmotic gradient, removing water from the brain and decreasing ICP 76 . Hypertonic saline may lower ICP faster, further, and for longer than mannitol 17 ; however, no trials have directly compared these agents in TBM.
Raised intracranial pressure surgical management
Hydrocephalus VP shunting has long been standard practice for hydrocephalus but may be associated with complications 77,78 . EVD may be used for temporary drainage of CSF, and to assess the benefit of a VP shunt in patients with an altered sensorium. With endoscopic third ventriculostomy (ETV), CSF is drained internally by connecting the ventricles with the subarachnoid space via a stoma in the floor of the third ventricle. ETV is particularly challenging in TBM and experience is required 79,80 .
Mass lesions
Surgical excision for tuberculomas is uncommon but may be indicated depending on their size, location, expansion, and clinical consequences. Surgery is more commonly needed for TB abscesses (drainage and/or excision).
those with low utility like AAFB, culture. Imaging must always be contrasted unless contraindicated Risks of prolonged hospital admission should include DVT.
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